Frank M. Klenke - Concepedia

Author

Frank M. Klenke

Also Known As

Christoph E. Albers, F Klenke, F M Klenke, F. Klenke, F. M. Klenke, F.M. Klenke, Frank Michael Klenke, Frank Klenke, Frank M Klenke, Frank M. Klenke

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Bern University of Bern German Cancer Research Center Heidelberg University Charité - Universitätsmedizin Berlin

About

Frank M. Klenke is an author at University Hospital of Bern specializing in medicine, orthopaedics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	945
2	Biomedical Engineering	4	4	306
3	Engineering	3	3	278
4	Health Sciences	1	1	39
5	Biostatistics	1	1	39

Frank M. Klenke

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Giant Cell Tumor of Bone: Risk Factors for Recurrence Frank M. Klenke, Doris E. Wenger, Carrie Y. Inwards, Clinical Orthopaedics and Related Research	2010	370
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study James Glasbey, Adesoji Ademuyiwa, Adewale Adisa, The Lancet Oncology	2021	280
<i>In vitro</i>cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations Christoph E. Albers, Klaus A. Siebenrock, Régine Landmann, Nanotoxicology NanoparticlesOrthopaedic BiomaterialsAntimicrobial PackagingNanotherapeuticsEngineering	2011	249
Impact of pore size on the vascularization and osseointegration of ceramic bone substitutes <i>in vivo</i> Frank M. Klenke, Yuelian Liu, Huipin Yuan, Journal of Biomedical Materials Research Part A	2007	220
Incidence, Predictive Factors, and Prognosis of Chondrosarcoma in Patients with Ollier Disease and Maffucci Syndrome: An International Multicenter Study of 161 Patients S. H. M. Verdegaal, Judith V.M.G. Bovée, Twinkal C. Pansuriya, The Oncologist	2011	213
Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors Andreas H. Krieg, Franz Hefti, Bernhard M. Speth, Annals of Oncology Synovial SarcomasSurgical OncologyMedicineSurgical PathologyMulticenter Retrospective Analysis	2010	204
Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. Amir Abdollahi, Kenneth E. Lipson, Axel Sckell, PubMed Angiogenesis InhibitorPathologyBlood PerfusionGliomaTumor Biology	2003	159
Recurrent Giant Cell Tumor of Long Bones: Analysis of Surgical Management Frank M. Klenke, Doris E. Wenger, Carrie Y. Inwards, Clinical Orthopaedics and Related Research	2010	128
Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients Alessandra Longhi, Stefan Bielack, R. J. Grimer, European Journal of Cancer Surgical OncologyExtraskeletal OsteosarcomaMedicineSurgical PathologyOncology	2017	84
The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice Frank M. Klenke, Martha-Maria Gebhard, V. Ewerbeck, BMC Cancer	2006	69

Page 1